ESR1 and breast cancer: We explored its mechanism and found that the combination can inhibit the downstream genes related to the transcriptional function of ERα, including GREB1, PGR and PS2, which are all involved the estrogen signaling pathway, is highly expressed in estrogen receptor-positive breast cancer cells, and its expression is often upregulated by estrogen stimulation.